Volodymyr Nikolenko is an Investor at Royalty Pharma, whose known portfolio counts 10 companies.
Is Volodymyr Nikolenko a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Investor at Royalty Pharma, whose known portfolio counts 10 companies
- Zenas BioPharma
- Zymeworks
- Revolution Medicines
- Elektrofi
- Kailera Therapeutics
- Syndax Pharmaceuticals
- Cytokinetics
- Denali Therapeutics
- Teva Pharmaceuticals
- Ascendis Pharma
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Pharma and Pharma Royalties fall inside that listing.
Royalty Pharma appears in Growth, Late-Stage and Series B rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Volodymyr Nikolenko matches their raise.
Colleagues at Royalty Pharma
Pablo Legorreta
Founder & Chief Executive Officer
New York City, United States
Alim Ladha
Research and Investments
New York, United States
Kristen Overly
Research and Investments
New York, United States
Sam Glazer
Senior Associate, Research & Investments
San Francisco, United States
Frequently asked questions
Who is Volodymyr Nikolenko?
Volodymyr Nikolenko is a private equity investor and venture debt investor based in New York, United States, listed as Investor at Royalty Pharma. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Volodymyr Nikolenko personally.
What does Volodymyr Nikolenko invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Pharma and Pharma Royalties. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Volodymyr Nikolenko invest at?
Royalty Pharma appears in Growth, Late-Stage and Series B rounds across its known deals, and Volodymyr Nikolenko is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Volodymyr Nikolenko listed at?
Volodymyr Nikolenko is listed as Investor at Royalty Pharma. 4 other people in the database share a firm with Volodymyr Nikolenko.
How do I contact Volodymyr Nikolenko?
An email address, a phone number and a LinkedIn page are on file for Volodymyr Nikolenko. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal